Opus Bank Irvine (CA) (OPB) Drops 7.1% on January 25

Equities Staff |

Opus Bank Irvine (CA) (OPB) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 7.1% to $30.90, a loss of $-2.36 per share. Starting at an opening price of $33.03 a share, the stock traded between $30.16 and $33.61 over the course of the trading day. Volume was 221,203 shares over 2,477 trades, against an average daily volume of 204,375 shares and a total float of 28.1 million.

The losses send Opus Bank Irvine (CA) down to a market cap of $868.32 million. In the last year, Opus Bank Irvine (CA) has traded between $41.49 and $25.33, and its 50-day SMA is currently $36.63 and 200-day SMA is $35.68.

The stock has a P/E Ratio of 26.6.

Opus Bank is a state chartered commercial bank. It provides relationship based banking products, services and loan products for small to mid-sized commercial businesses, entrepreneurs, real estate investor, professionals and consumers.

Opus Bank Irvine (CA) is based out of Irvine, CA and has some 550 employees. Its CEO is Stephen H. Gordon.

For a complete fundamental analysis analysis of Opus Bank Irvine (CA), check out Equities.com’s Stock Valuation Analysis report for OPB. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

OncoSec Medical Incorporated

OncoSec Medical Inc is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the…

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…